Učitavanje...
不同剂量紫杉醇联合卡铂一线治疗晚期非小细胞肺癌的临床研究
BACKGROUND AND OBJECTIVE: The combination of pacilitaxel and carboplatin has become a widely used regimen in frst-line therapy of advanced NSCLC. The aim of this study is to compare the efcacy and safety of paclitaxel plus carboplatin at two dose levels in the frst-line treatment of advanced NSCLC p...
Spremljeno u:
| Izdano u: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
中国肺癌杂志编辑部
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5999718/ https://ncbi.nlm.nih.gov/pubmed/21496430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2011.04.04 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|